Psoriasis, Immunity, and Functional Medicine: Looking Beyond the Skin
A. Aljawawdeh
6/1/20262 min read
Psoriasis, Immunity, and Functional Medicine: Looking Beyond the Skin
Psoriasis is more than a skin condition—it is a chronic immune-mediated inflammatory disease. Research has shown that key immune pathways involving TNF-α, IL-17, and IL-23 drive inflammation, leading to the characteristic skin plaques seen in psoriasis.
From a functional medicine perspective, psoriasis may be influenced by factors beyond genetics, including gut health, nutrition, metabolic dysfunction, stress, and environmental triggers. Studies have demonstrated links between psoriasis and obesity, insulin resistance, cardiovascular disease, and alterations in the gut microbiome, supporting the concept of psoriasis as a systemic inflammatory condition.
A comprehensive evaluation may include inflammatory markers (hs-CRP, ESR), vitamin D status, metabolic markers (fasting insulin, hemoglobin A1c), thyroid function, and assessment of gut health when gastrointestinal symptoms are present. Vitamin D deficiency, gut dysbiosis, chronic stress, and poor metabolic health have all been associated with increased inflammatory activity.
Functional medicine does not replace dermatologic treatment but complements conventional care by identifying modifiable factors that may contribute to immune dysregulation. Optimizing nutrition, supporting gut health, reducing stress, improving sleep, and addressing metabolic dysfunction may help decrease inflammation and improve overall well-being.
As the scientific understanding of psoriasis continues to evolve, an integrative approach that combines evidence-based medical treatment with personalized lifestyle and root-cause interventions offers a promising strategy for supporting long-term health and quality of life.
References
Armstrong, A. W., Harskamp, C. T., & Armstrong, E. J. (2013). Psoriasis and metabolic syndrome: A systematic review and meta-analysis of observational studies. Journal of the American Academy of Dermatology, 68(4), 654–662. https://doi.org/10.1016/j.jaad.2012.08.015
Griffiths, C. E. M., Armstrong, A. W., Gudjonsson, J. E., & Barker, J. N. W. N. (2021). Psoriasis. The Lancet, 397(10281), 1301–1315. https://doi.org/10.1016/S0140-6736(20)32549-6
Kamiya, K., Kishimoto, M., Sugai, J., Komine, M., & Ohtsuki, M. (2019). Risk factors for the development of psoriasis. International Journal of Molecular Sciences, 20(18), 4347. https://doi.org/10.3390/ijms20184347
Lowes, M. A., Suárez-Fariñas, M., & Krueger, J. G. (2014). Immunology of psoriasis. Annual Review of Immunology, 32, 227–255. https://doi.org/10.1146/annurev-immunol-032713-120225
Polak, K., Bergler-Czop, B., Szczepanek, M., Wojciechowska, K., Frątczak, A., & Kiss, N. (2021). Psoriasis and gut microbiome—Current state of art. International Journal of Molecular Sciences, 22(9), 4529. https://doi.org/10.3390/ijms22094529
Rendon, A., & Schäkel, K. (2019). Psoriasis pathogenesis and treatment. International Journal of Molecular Sciences, 20(6), 1475. https://doi.org/10.3390/ijms20061475
Upala, S., Sanguankeo, A., & Congrete, S. (2017). Association between vitamin D deficiency and psoriasis: Evidence from a meta-analysis. International Journal of Dermatology, 56(6), 581–586. https://doi.org/10.1111/ijd.13490
National Psoriasis Foundation. (2025). Psoriasis statistics and disease information. Retrieved from https://www.psoriasis.org
Quick Links
Reach out anytime for personalized care
info@evexiamedicine.com
(614) 555-0298
© 2022. All rights reserved.
Call